LEADER 01971cam a2200433 i 4500001    99104290713506421
005    20240509055713.0
008    170117s2017    enk      b    001 0 eng^^
010    2017001662
016 7  101698744 |2DNLM
019    956960087
020    9781138285248 (hbk : alk. paper)
020    1138285242 (hbk : alk. paper)
020     |z9781315269139 (ebk)
035    (NjP)10429071-princetondb
035     |z(OCoLC)956960087
035     |z(NjP)Voyager10429071
035    (OCoLC)ocn957504175
040    DNLM/DLC |beng |erda |cDLC |dBTCTA |dYDX |dBDX |dNLM |dOCLCO
042    pcc
043    n-us---
050 00 RC270.3.R33 |bP47 2017
060 10 QZ 11 AA1
082 00 616.99/40757 |223
100 1  Perkins, Barbara Bridgman, |eauthor.
245 10 Cancer, radiation therapy, and the market / |cBarbara Bridgman Perkins.
264  1 London ;New York : |bRoutledge, Taylor & Francis Group, |c2017.
300    243 pages ; |c24 cm.
336    text |2rdacontent
337    unmediated |2rdamedia
338    volume |2rdacarrier
490 1  Routledge studies in the history of science, technology and medicine
504    Includes bibliographical references and index.
505 0  Introduction : medical care as trade -- The medical radium industry -- The General Electric Company dominates X-ray -- Competing research universities -- Megavoltage competition in academia and industry -- Medicine's nuclear arms race -- An economic success story at Stanford -- Radiation therapy politics -- Speculating on proton therapy -- Rationalizing radiation therapy, reforming health care -- Conclusion : choosing health over wealth.
830  0 Routledge studies in the history of science, technology, and medicine
852 0   |bf |hRC270.3.R33 |iP47 2017
902    kl |bs |6a |7m |dv |f1 |e20171031
904    kl |ba |hm |cb |e20171031
914    (OCoLC)ocn957504175 |bOCoLC |cmatch |d20240508 |eprocessed |f957504175